Selected research
Industry Research
CRISPR-Cas9 Gene Editing Service Industry Research Report 2026
Market perspective
The global CRISPR-Cas9 Gene Editing Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the CRISPR-Cas9 Gene Editing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the CRISPR-Cas9 Gene Editing Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the CRISPR-Cas9 Gene Editing Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of CRISPR-Cas9 Gene Editing Service include AMSBIO, GenScript, Merck, Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, DefiniGEN, Synthego and Biocytogen, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global CRISPR-Cas9 Gene Editing Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to CRISPR-Cas9 Gene Editing Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
CRISPR-Cas9 Gene Editing Service Market by Company
AMSBIO
GenScript
Merck
Editas Medicine
Intellia Therapeutics
CRISPR Therapeutics
DefiniGEN
Synthego
Biocytogen
Caribou
Horizon Discovery Ltd.
EdiGene, Inc.
DetaiBio
CRISPR-Cas9 Gene Editing Service Segment by Type
Knock-in Gene Editing Service
Knock-out Gene Editing Service
Other
CRISPR-Cas9 Gene Editing Service Segment by Application
Cell Line Construction
Animal Models
Bioagriculture
Other
CRISPR-Cas9 Gene Editing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CRISPR-Cas9 Gene Editing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of CRISPR-Cas9 Gene Editing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CRISPR-Cas9 Gene Editing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of CRISPR-Cas9 Gene Editing Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Knock-in Gene Editing Service
- Knock-out Gene Editing Service
- Other
Applications
- Cell Line Construction
- Animal Models
- Bioagriculture
- Other
Companies covered
- AMSBIO
- GenScript
- Merck
- Editas Medicine
- Intellia Therapeutics
- CRISPR Therapeutics
- DefiniGEN
- Synthego
- Biocytogen
- Caribou
- Horizon Discovery Ltd.
- EdiGene, Inc.
- DetaiBio
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 CRISPR-Cas9 Gene Editing Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Knock-in Gene Editing Service
- 2.2.3 Knock-out Gene Editing Service
- 2.2.4 Other
- 2.3 CRISPR-Cas9 Gene Editing Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Cell Line Construction
- 2.3.3 Animal Models
- 2.3.4 Bioagriculture
- 2.3.5 Other
- 2.4 Assumptions and Limitations
3 CRISPR-Cas9 Gene Editing Service Breakdown Data by Type
- 3.1 Global CRISPR-Cas9 Gene Editing Service Historic Market Size by Type (2021-2026)
- 3.2 Global CRISPR-Cas9 Gene Editing Service Forecasted Market Size by Type (2027-2032)
4 CRISPR-Cas9 Gene Editing Service Breakdown Data by Application
- 4.1 Global CRISPR-Cas9 Gene Editing Service Historic Market Size by Application (2021-2026)
- 4.2 Global CRISPR-Cas9 Gene Editing Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global CRISPR-Cas9 Gene Editing Service Market Perspective (2021-2032)
- 5.2 Global CRISPR-Cas9 Gene Editing Service Growth Trends by Region
- 5.2.1 Global CRISPR-Cas9 Gene Editing Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 CRISPR-Cas9 Gene Editing Service Historic Market Size by Region (2021-2026)
- 5.2.3 CRISPR-Cas9 Gene Editing Service Forecasted Market Size by Region (2027-2032)
- 5.3 CRISPR-Cas9 Gene Editing Service Market Dynamics
- 5.3.1 CRISPR-Cas9 Gene Editing Service Industry Trends
- 5.3.2 CRISPR-Cas9 Gene Editing Service Market Drivers
- 5.3.3 CRISPR-Cas9 Gene Editing Service Market Challenges
- 5.3.4 CRISPR-Cas9 Gene Editing Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top CRISPR-Cas9 Gene Editing Service Players by Revenue
- 6.1.1 Global Top CRISPR-Cas9 Gene Editing Service Players by Revenue (2021-2026)
- 6.1.2 Global CRISPR-Cas9 Gene Editing Service Revenue Market Share by Players (2021-2026)
- 6.2 Global CRISPR-Cas9 Gene Editing Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of CRISPR-Cas9 Gene Editing Service Head Office and Area Served
- 6.4 Global CRISPR-Cas9 Gene Editing Service Players, Product Type & Application
- 6.5 Global CRISPR-Cas9 Gene Editing Service Manufacturers Established Date
- 6.6 Global CRISPR-Cas9 Gene Editing Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America CRISPR-Cas9 Gene Editing Service Market Size (2021-2032)
- 7.2 North America CRISPR-Cas9 Gene Editing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America CRISPR-Cas9 Gene Editing Service Market Size by Country (2021-2026)
- 7.4 North America CRISPR-Cas9 Gene Editing Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe CRISPR-Cas9 Gene Editing Service Market Size (2021-2032)
- 8.2 Europe CRISPR-Cas9 Gene Editing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe CRISPR-Cas9 Gene Editing Service Market Size by Country (2021-2026)
- 8.4 Europe CRISPR-Cas9 Gene Editing Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific CRISPR-Cas9 Gene Editing Service Market Size (2021-2032)
- 9.2 Asia-Pacific CRISPR-Cas9 Gene Editing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific CRISPR-Cas9 Gene Editing Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific CRISPR-Cas9 Gene Editing Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America CRISPR-Cas9 Gene Editing Service Market Size (2021-2032)
- 10.2 South America CRISPR-Cas9 Gene Editing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America CRISPR-Cas9 Gene Editing Service Market Size by Country (2021-2026)
- 10.4 South America CRISPR-Cas9 Gene Editing Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa CRISPR-Cas9 Gene Editing Service Market Size (2021-2032)
- 11.2 Middle East & Africa CRISPR-Cas9 Gene Editing Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa CRISPR-Cas9 Gene Editing Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa CRISPR-Cas9 Gene Editing Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 AMSBIO
- 12.1.1 AMSBIO Company Information
- 12.1.2 AMSBIO Business Overview
- 12.1.3 AMSBIO Revenue in CRISPR-Cas9 Gene Editing Service Business (2021-2026)
- 12.1.4 AMSBIO CRISPR-Cas9 Gene Editing Service Product Portfolio
- 12.1.5 AMSBIO Recent Developments
- 12.2 GenScript
- 12.2.1 GenScript Company Information
- 12.2.2 GenScript Business Overview
- 12.2.3 GenScript Revenue in CRISPR-Cas9 Gene Editing Service Business (2021-2026)
- 12.2.4 GenScript CRISPR-Cas9 Gene Editing Service Product Portfolio
- 12.2.5 GenScript Recent Developments
- 12.3 Merck
- 12.3.1 Merck Company Information
- 12.3.2 Merck Business Overview
- 12.3.3 Merck Revenue in CRISPR-Cas9 Gene Editing Service Business (2021-2026)
- 12.3.4 Merck CRISPR-Cas9 Gene Editing Service Product Portfolio
- 12.3.5 Merck Recent Developments
- 12.4 Editas Medicine
- 12.4.1 Editas Medicine Company Information
- 12.4.2 Editas Medicine Business Overview
- 12.4.3 Editas Medicine Revenue in CRISPR-Cas9 Gene Editing Service Business (2021-2026)
- 12.4.4 Editas Medicine CRISPR-Cas9 Gene Editing Service Product Portfolio
- 12.4.5 Editas Medicine Recent Developments
- 12.5 Intellia Therapeutics
- 12.5.1 Intellia Therapeutics Company Information
- 12.5.2 Intellia Therapeutics Business Overview
- 12.5.3 Intellia Therapeutics Revenue in CRISPR-Cas9 Gene Editing Service Business (2021-2026)
- 12.5.4 Intellia Therapeutics CRISPR-Cas9 Gene Editing Service Product Portfolio
- 12.5.5 Intellia Therapeutics Recent Developments
- 12.6 CRISPR Therapeutics
- 12.6.1 CRISPR Therapeutics Company Information
- 12.6.2 CRISPR Therapeutics Business Overview
- 12.6.3 CRISPR Therapeutics Revenue in CRISPR-Cas9 Gene Editing Service Business (2021-2026)
- 12.6.4 CRISPR Therapeutics CRISPR-Cas9 Gene Editing Service Product Portfolio
- 12.6.5 CRISPR Therapeutics Recent Developments
- 12.7 DefiniGEN
- 12.7.1 DefiniGEN Company Information
- 12.7.2 DefiniGEN Business Overview
- 12.7.3 DefiniGEN Revenue in CRISPR-Cas9 Gene Editing Service Business (2021-2026)
- 12.7.4 DefiniGEN CRISPR-Cas9 Gene Editing Service Product Portfolio
- 12.7.5 DefiniGEN Recent Developments
- 12.8 Synthego
- 12.8.1 Synthego Company Information
- 12.8.2 Synthego Business Overview
- 12.8.3 Synthego Revenue in CRISPR-Cas9 Gene Editing Service Business (2021-2026)
- 12.8.4 Synthego CRISPR-Cas9 Gene Editing Service Product Portfolio
- 12.8.5 Synthego Recent Developments
- 12.9 Biocytogen
- 12.9.1 Biocytogen Company Information
- 12.9.2 Biocytogen Business Overview
- 12.9.3 Biocytogen Revenue in CRISPR-Cas9 Gene Editing Service Business (2021-2026)
- 12.9.4 Biocytogen CRISPR-Cas9 Gene Editing Service Product Portfolio
- 12.9.5 Biocytogen Recent Developments
- 12.10 Caribou
- 12.10.1 Caribou Company Information
- 12.10.2 Caribou Business Overview
- 12.10.3 Caribou Revenue in CRISPR-Cas9 Gene Editing Service Business (2021-2026)
- 12.10.4 Caribou CRISPR-Cas9 Gene Editing Service Product Portfolio
- 12.10.5 Caribou Recent Developments
- 12.11 Horizon Discovery Ltd.
- 12.11.1 Horizon Discovery Ltd. Company Information
- 12.11.2 Horizon Discovery Ltd. Business Overview
- 12.11.3 Horizon Discovery Ltd. Revenue in CRISPR-Cas9 Gene Editing Service Business (2021-2026)
- 12.11.4 Horizon Discovery Ltd. CRISPR-Cas9 Gene Editing Service Product Portfolio
- 12.11.5 Horizon Discovery Ltd. Recent Developments
- 12.12 EdiGene, Inc.
- 12.12.1 EdiGene, Inc. Company Information
- 12.12.2 EdiGene, Inc. Business Overview
- 12.12.3 EdiGene, Inc. Revenue in CRISPR-Cas9 Gene Editing Service Business (2021-2026)
- 12.12.4 EdiGene, Inc. CRISPR-Cas9 Gene Editing Service Product Portfolio
- 12.12.5 EdiGene, Inc. Recent Developments
- 12.13 DetaiBio
- 12.13.1 DetaiBio Company Information
- 12.13.2 DetaiBio Business Overview
- 12.13.3 DetaiBio Revenue in CRISPR-Cas9 Gene Editing Service Business (2021-2026)
- 12.13.4 DetaiBio CRISPR-Cas9 Gene Editing Service Product Portfolio
- 12.13.5 DetaiBio Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst